News

2022 May 15

Benefits of PSA Prostate Cancer Screening Found to Be More Favorable than Previous Estimates, Especially for Blacks

New research led by investigators from Weill Cornell Medicine, Fred Hutchinson Cancer Center, University Hospitals Cleveland and Case Western Reserve University found that prostate cancer screening with the prostate specific... Read more

2022 May 09

Tumor Release of Lactate Forces Nearby Cells into Supportive Role

Tumors can force neighboring cells into supporting cancer growth by releasing lactate into their local environment, according to researchers at Weill Cornell Medicine. The findings pave the way for future drug treatments... Read more

2022 May 09

T Cell Behavior Determines Which Tumors Respond to Treatment

Immunotherapy unleashes the power of the immune system to fight cancer. However, for some patients, immunotherapy doesn’t work, and new research may help explain why. When immune cells called T lymphocytes infiltrate... Read more

2022 May 04

Advance in Understanding Cell Division Could Lead to New Cancer Treatments

A protein called CDC7, long thought to play an essential role early in the cell division process, is in fact replaceable by another protein called CDK1, according to a study by investigators at Weill Cornell Medicine and the... Read more

a doctor giving results to a patient who is out of the shot

2022 Apr 22

Less Prostate Cancer Screening Reduces Overdiagnosis but May Miss Aggressive Cases

Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men with low-grade prostate... Read more

2022 Apr 13

Tumors Change Their Metabolism to Spread More Effectively

Cancer cells can disrupt a metabolic pathway that breaks down fats and proteins to boost the levels of a byproduct called methylmalonic acid, thereby driving metastasis, according to research led by scientists at Weill... Read more

2022 Mar 16

A Potential New Target for Cancer Immunotherapies

Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers at Weill Cornell Medicine and... Read more

2022 Mar 10

New Collaborations Win Funding from Starr Cancer Consortium

Two multi-institutional teams led by Weill Cornell Medicine scientists have been awarded grant support from the Starr Cancer Consortium . Both grants will fund work applying new technologies to develop more detailed... Read more

2022 Mar 03

Three Weill Cornell Medicine Faculty Win ASCI Young Physician-Scientist Awards

Three Weill Cornell Medicine faculty members have received Young Physician-Scientist Awards from the American Society for Clinical Investigation. The 2022 award recipients are Drs. Bishoy M. Faltas, Gunisha Kaur and Hasina... Read more

2022 Feb 18

Patient Possibly Cured of HIV Infection by Special Stem-Cell Transplant

A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping HIV antiretroviral drug treatment, suggesting a cure, according... Read more

2022 Feb 11

Newly Funded New York City Center Aims to Reduce Health Disparities in Chronic Disease

A multi-institutional group in New York City has united to address health disparities in multiple chronic diseases through a new collaborative center. The vision of the Center to Improve Chronic Disease Outcomes through... Read more

Illustration of red and white blood cells. Credit: Shutterstock

2022 Jan 28

Researchers Identify Key Regulator of Blood Stem Cell Development

Illustration of red and white blood cells. Credit: Shutterstock A protein that masterminds the way DNA is wrapped within chromosomes has a major role in the healthy functioning of blood stem cells, which produce all blood... Read more

2022 Jan 27

Partnership with Dr. Ari M. Melnick: New View of Lymph Nodes Shows Immune Cells in Real Time

Cornell researchers have for the first time successfully imaged the entire depth of the lymph nodes in a living mouse using three-photon microscopy. The breakthrough technique’s micrometer clarity and noninvasive nature... Read more

Illustration of the lymphatic system. Credit: Shutterstock

2022 Jan 19

Research Illuminates How Melanoma Readies Lymph Nodes for Tumor Spread

Illustration of the lymphatic system. Credit: Shutterstock Melanoma cells release small extracellular packages containing the protein nerve growth factor receptor, which primes nearby lymph nodes for tumor metastases,... Read more

2022 Jan 04

Portable Prostate Cancer Test May Help Reach Underserved Men

A highly portable and rapid prostate cancer screening kit could provide early warning to populations with higher incidence of prostate cancer and particularly those with limited access to health care, such as African... Read more

2022 Jan 03

Dr. Ari Melnick's Study: Lymphoma Cell Metabolism May Provide New Cancer Target

Aggressive and relatively common lymphomas called diffuse large B cell lymphomas (DLBCLs) have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves, according to a study... Read more

2021 Dec 15

Reducing Copper in the Body Alters Cancer Metabolism to Reduce Risk of Aggressive Breast Cancer

Depleting copper levels may reduce the production of energy that cancer cells need to travel and establish themselves in other parts of the body by a process referred to as metastasis, according to a new study by... Read more

Silvia Formenti, M.D., is pioneering the use of radiation for immunotherapy in cancer

2021 Dec 09

Led by Dr. Silvia C. Formenti: Department of Defense Awards Weill Cornell Medicine New Grant for Breast Cancer Research

Weill Cornell Medicine has been awarded a nearly $6.5 million, four-year grant from the Department of Defense as part of a multi-institutional Transformative Breast Cancer Consortium. The award will fund research on the... Read more

2021 Dec 09

Dr. Olivier Elemento's study: Tumors differ depending on age of cancer patients

Investigators at Weill Cornell Medicine have identified significant differences in the molecular characteristics of tumors from younger and older cancer patients across several cancer types. Their research, published Dec. 7... Read more

2021 Nov 23

Led by Dr. Jaffrey: National Human Genome Research Institute Funds $12.2 Million Center at Weill Cornell Medicine to Study RNA Modifications

The National Human Genome Research Institute has funded a multi-institutional Center of Excellence in Genome Sciences (CEGS) , based at Weill Cornell Medicine, to develop new tools to study the major product of the human... Read more